Vor Biopharma Inc.
General ticker "VOR" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $121.7M (TTM average)
Vor Biopharma Inc. does not follow the US Stock Market performance with the rate: -25.6%.
Estimated limits based on current volatility of 3.6%: low 16.86$, high 18.12$
Factors to consider:
- Total employees count: 159 (-5.4%) as of 2024
- Top business risk factors: Clinical trial failure, Capital shortage, Regulatory and compliance, Market competition, IP protection failure
- Price in estimated range
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [8.26$, 26.10$]
- 2026-12-31 to 2027-12-31 estimated range: [4.82$, 16.32$]
Financial Metrics affecting the VOR estimates:
- Positive: with PPE of -5.0 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Inventory ratio change, % of 0 <= 0
- Positive: Shareholder equity ratio, % of -35.40 <= 19.19
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Negative: negative Net income
Short-term VOR quotes
Long-term VOR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $126.04MM | $121.19MM | $371.64MM |
| Operating Income | $-126.04MM | $-121.19MM | $-371.64MM |
| Non-Operating Income | $8.17MM | $4.27MM | $-324.34MM |
| R&D Expense | $94.31MM | $93.31MM | $321.53MM |
| Income(Loss) | $-117.86MM | $-116.91MM | $-695.98MM |
| Net Income(Loss)* | $-117.86MM | $-116.91MM | $-695.98MM |
| Stockholders Equity | $150.72MM | $96.66MM | $-164.31MM |
| Assets | $198.13MM | $142.89MM | $464.13MM |
| Operating Cash Flow | $-100.29MM | $-99.66MM | $-142.71MM |
| Capital expenditure | $1.07MM | $0.23MM | $0.94MM |
| Investing Cash Flow | $71.01MM | $96.86MM | $-48.80MM |
| Financing Cash Flow | $2.94MM | $53.39MM | $503.81MM |
| Earnings Per Share** | $-35.08 | $-34.03 | $-70.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.